AbbVie could be heading for its second acquisition in the space of a month, with reports emerging of late-stage negotiations with Gilgamesh Pharmaceuticals, a central nervous system (CNS) drug ...
Gilgamesh, the builder-king of Uruk, and Achilles, the destroyer-prince of Phthia, represent the primal archetypes of the ...
Iraqi artist’s flood-inspired installation opens wider conversation about systems that sustain life ...
Less than a month after reports of takeover talks between AbbVie and Gilgamesh Pharma first emerged, the pair have gone public with details of a $1.2 billion deal – but it is not an acquisition. It ...
Is Christianity a copycat religion?” It is an essential question that critics of Christianity often ask, and rightly so.
In 1853, Hormuzad Rassam discovered fragments of an ancient Sumerian text which is now considered to be the first great work of literature our civilization ever produced. After its translation it was ...
Until the Scientific Revolution most human cultures did not believe in progress. They thought the golden age was in the past, and that the world was stagnant, if not deteriorating. Strict adherence to ...
AbbVie (NYSE:ABBV) has agreed to acquire from Gilgamesh Pharmaceuticals its lead investigational candidate, Bretisilocin, for up to $1.2 billion. The deal includes upfront payment plus development ...